Symbol="ZYME"
AssetType="Common Stock"
Name="Zymeworks Inc. Common Stock"
Description="Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops and markets biotherapeutic products for the treatment of cancer. The company is headquartered in Vancouver, Canada."
CIK="1937653"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="529096000"
EBITDA="193794000"
PERatio="2.566"
PEGRatio="0"
BookValue="6.63"
DividendPerShare="0"
DividendYield="0"
EPS="3.04"
RevenuePerShareTTM="6.71"
ProfitMargin="0.416"
OperatingMarginTTM="0.417"
ReturnOnAssetsTTM="0.24"
ReturnOnEquityTTM="0.554"
RevenueTTM="447704000"
GrossProfitTTM="203779000"
DilutedEPSTTM="3.04"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.287"
AnalystTargetPrice="13.97"
TrailingPE="2.566"
ForwardPE="-"
PriceToSalesRatioTTM="13.31"
PriceToBookRatio="1.782"
EVToRevenue="5.89"
EVToEBITDA="-0.815"
Beta="0.942"
num_52WeekHigh="10.8"
num_52WeekLow="4.11"
num_50DayMovingAverage="7.86"
num_200DayMovingAverage="8.38"
SharesOutstanding="67827000"
DividendDate="None"
ExDividendDate="None"
symbol="ZYME"
open="7.94"
high="7.94"
low="7.62"
price="7.66"
volume="213220.00"
latest_trading_day="2023-08-24"
previous_close="7.97"
change="-0.31"
change_percent="-3.8896%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="49"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="623132"
Change_recent_avg="-0.02"
Delta_recent_avg="0.41"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="1094"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="626"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
